For now, life actuaries are monitoring the emerging evidence closely
Across these trials, semaglutide treatment was associated with greater reductions in body weight and larger decreases in insulin resistance compared with placebo or active comparators
Gain valuable insights into potential risks, precautions, and safety measures associated with Eliquis to make informed decisions about your health
When used alongside other glucose-lowering agents, semaglutide may increase the risk of hypoglycemia, necessitating dose adjustments of concomitant medications
When evaluating compounding pharmacies, researchers should verify that the pharmacy is properly licensed, uses third-party testing for potency and purity, follows current good manufacturing practices, and has a track record of regulatory compliance
Lancet 403 (10437), 16351648 (2024)